{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:24:15Z","timestamp":1770369855314,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-03935-7","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:34:34Z","timestamp":1770233674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing the diagnostic performance of metabolic indices in metabolic dysfunction-associated fatty liver disease patients: a retrospective cross-sectional study"],"prefix":"10.1186","volume":"31","author":[{"given":"Ehsan","family":"Bahrami Hezaveh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadamin","family":"Noorafrooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Sheikhzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azin","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Yadegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manouchehr","family":"Nakhjavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Esteghamati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soghra","family":"Rabizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"1","key":"3935_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"6","key":"3935_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"4","key":"3935_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"key":"3935_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154170","volume":"111","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111:154170.","journal-title":"Metabolism"},{"issue":"8","key":"3935_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"key":"3935_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab JP, Arrese M, Trauner M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol. 2018;13:321\u201350.","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"3935_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, et al. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28(5):528\u201362.","journal-title":"Endocr Pract"},{"key":"3935_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nu14234969","author":"J Wang","year":"2022","unstructured":"Wang J, Yan S, Cui Y, Chen F, Piao M, Cui W. The diagnostic and prognostic value of the triglyceride-glucose index in metabolic dysfunction-associated fatty liver disease (MAFLD): a systematic review and meta-analysis. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14234969.","journal-title":"Nutrients"},{"issue":"1","key":"3935_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40200-021-00941-w","volume":"21","author":"E Taheri","year":"2022","unstructured":"Taheri E, Pourhoseingholi MA, Moslem A, Hassani AH, Mousavi Jarrahi A, AsadzadehAghdaei H, et al. The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults. J Diabetes Metab Disord. 2022;21(1):97\u2013107.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"3935_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01560-3","volume":"20","author":"F Xie","year":"2021","unstructured":"Xie F, Pei Y, Zhou Q, Cao D, Wang Y. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. Lipids Health Dis. 2021;20(1):132.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3935_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20(1):134.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3935_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00731-x","volume":"27","author":"S Samimi","year":"2022","unstructured":"Samimi S, Rajabzadeh S, Rabizadeh S, Nakhjavani M, Nakhaei P, Avanaki FA, et al. Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes. Eur J Med Res. 2022;27(1):112.","journal-title":"Eur J Med Res"},{"key":"3935_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1035418","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Duan S, Wang C, Wang Y, Peng H, Niu Z, et al. Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: a retrospective case-control study. Front Endocrinol (Lausanne). 2022;13:1035418.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"3935_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070189","volume":"13","author":"M Chang","year":"2023","unstructured":"Chang M, Shao Z, Shen G. Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants. BMJ Open. 2023;13(5):e070189.","journal-title":"BMJ Open"},{"issue":"4","key":"3935_CR15","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s11135-017-0584-6","volume":"52","author":"R Johnston","year":"2018","unstructured":"Johnston R, Jones K, Manley D. Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour. Qual Quant. 2018;52(4):1957\u201376.","journal-title":"Qual Quant"},{"issue":"2","key":"3935_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70(2):711\u201324.","journal-title":"Hepatology"},{"issue":"25","key":"3935_CR17","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.3748\/wjg.v29.i25.3999","volume":"29","author":"SC Pal","year":"2023","unstructured":"Pal SC, M\u00e9ndez-S\u00e1nchez N. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World J Gastroenterol. 2023;29(25):3999\u20134008.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3935_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"6","key":"3935_CR19","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/jgh.15353","volume":"36","author":"M Ahadi","year":"2021","unstructured":"Ahadi M, Molooghi K, Masoudifar N, Namdar AB, Vossoughinia H, Farzanehfar M. A review of non-alcoholic fatty liver disease in non-obese and lean individuals. J Gastroenterol Hepatol. 2021;36(6):1497\u2013507.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"3935_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02526-5","volume":"24","author":"A Yadegar","year":"2025","unstructured":"Yadegar A, Mohammadi F, Seifouri K, Mokhtarpour K, Yadegar S, Bahrami Hazaveh E, et al. Surrogate markers of insulin resistance and coronary artery disease in type 2 diabetes: u-shaped TyG association and insights from machine learning integration. Lipids Health Dis. 2025;24(1):96.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3935_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0913-3","volume":"17","author":"R Zheng","year":"2018","unstructured":"Zheng R, Du Z, Wang M, Mao Y, Mao W. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. Lipids Health Dis. 2018;17(1):262.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3935_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01393-6","volume":"19","author":"W Guo","year":"2020","unstructured":"Guo W, Lu J, Qin P, Li X, Zhu W, Wu J, et al. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis. 2020;19(1):218.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"3935_CR23","first-page":"502","volume":"11","author":"AH Patel","year":"2023","unstructured":"Patel AH, Peddu D, Amin S, Elsaid MI, Minacapelli CD, Chandler TM, et al. Nonalcoholic fatty liver disease in lean\/nonobese and obese individuals: a comprehensive review on prevalence, pathogenesis, clinical outcomes, and treatment. J Clin Transl Hepatol. 2023;11(2):502\u201315.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"3935_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ajg.2016.318","volume":"112","author":"A Feldman","year":"2017","unstructured":"Feldman A, Eder SK, Felder TK, Kedenko L, Paulweber B, Stadlmayr A, et al. Clinical and metabolic characterization of lean Caucasian subjects with non-alcoholic fatty liver. Am J Gastroenterol. 2017;112(1):102\u201310.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"3935_CR25","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"issue":"5","key":"3935_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/met.2023.0276","volume":"22","author":"AL Han","year":"2024","unstructured":"Han AL, Lee HK, Shin SR. Diagnostic performance of insulin resistance indices for identifying metabolic dysfunction-associated fatty liver disease. Metab Syndr Relat Disord. 2024;22(5):402\u20139.","journal-title":"Metab Syndr Relat Disord"},{"key":"3935_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18030857","author":"IT Lin","year":"2021","unstructured":"Lin IT, Lee MY, Wang CW, Wu DW, Chen SC. Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese population. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18030857.","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"3935_CR28","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1210\/jc.2018-00554","volume":"103","author":"J Abildgaard","year":"2018","unstructured":"Abildgaard J, Danielsen ER, Dorph E, Thomsen C, Juul A, Ewertsen C, et al. Ectopic lipid deposition is associated with insulin resistance in postmenopausal women. J Clin Endocrinol Metab. 2018;103(9):3394\u2013404.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3935_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100835","volume":"5","author":"PC Eng","year":"2023","unstructured":"Eng PC, Forlano R, Tan T, Manousou P, Dhillo WS, Izzi-Engbeaya C. Non-alcoholic fatty liver disease in women - current knowledge and emerging concepts. JHEP Rep. 2023;5(10):100835.","journal-title":"JHEP Rep"},{"issue":"7","key":"3935_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"3935_CR31","first-page":"360","volume":"15","author":"V Khani","year":"2022","unstructured":"Khani V, Momeni Moghaddam A, Hatami B. Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population. Gastroenterol Hepatol Bed Bench. 2022;15(4):360\u20135.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"3935_CR32","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.2147\/DMSO.S221969","volume":"12","author":"C Tripolino","year":"2019","unstructured":"Tripolino C, Irace C, Cutruzzol\u00e0 A, Parise M, Barone M, Scicchitano C, et al. Hepatic steatosis index is associated with type 1 diabetes complications. Diabetes Metab Syndr Obes. 2019;12:2405\u201310.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"14","key":"3935_CR33","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.7150\/ijms.62010","volume":"18","author":"C Wang","year":"2021","unstructured":"Wang C, Cai Z, Deng X, Li H, Zhao Z, Guo C, et al. Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes. Int J Med Sci. 2021;18(14):3280\u20139.","journal-title":"Int J Med Sci"},{"issue":"10","key":"3935_CR34","volume":"16","author":"ES Thomson","year":"2024","unstructured":"Thomson ES, Oommen AT, S SV, Pillai G. Comparison of non-invasive liver fat scoring systems as markers of metabolic dysfunction-associated liver disease. Cureus. 2024;16(10):e72222.","journal-title":"Cureus"},{"issue":"1","key":"3935_CR35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12877-024-05483-3","volume":"24","author":"R Hashemi","year":"2024","unstructured":"Hashemi R, Rabizadeh S, Yadegar A, Mohammadi F, Rajab A, KarimpourReyhan S, et al. High prevalence of comorbidities in older adult patients with type 2 diabetes: a cross-sectional survey. BMC Geriatr. 2024;24(1):873.","journal-title":"BMC Geriatr"},{"issue":"12","key":"3935_CR36","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2337\/dc24-0475","volume":"47","author":"R Sun","year":"2024","unstructured":"Sun R, Wang J, Li M, Li J, Pan Y, Liu B, et al. Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analysis. Diabetes Care. 2024;47(12):2266\u201374.","journal-title":"Diabetes Care"},{"issue":"2","key":"3935_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70037","volume":"8","author":"E BahramiHezaveh","year":"2025","unstructured":"BahramiHezaveh E, Hashemi R, Noorafrooz M, Mohammadi F, Yadegar A, KarimpourReyhan S, et al. Estimated glucose disposal rate: a potential determinant for microvascular and macrovascular complications in type 2 diabetes. Endocrinol Diabetes Metabol. 2025;8(2):e70037.","journal-title":"Endocrinol Diabetes Metabol"},{"key":"3935_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109827","volume":"186","author":"M de Vries","year":"2022","unstructured":"de Vries M, Westerink J, El-Morabit F, Kaasjager H, de Valk HW. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes. Diabetes Res Clin Pract. 2022;186:109827.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"3935_CR39","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1007\/s10620-011-1807-7","volume":"56","author":"T Bulum","year":"2011","unstructured":"Bulum T, Kolari\u0107 B, Duvnjak L, Duvnjak M. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. Dig Dis Sci. 2011;56(12):3655\u201363.","journal-title":"Dig Dis Sci"},{"key":"3935_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1398265","volume":"15","author":"J Song","year":"2024","unstructured":"Song J, Ma R, Yin L. Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2024;15:1398265.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3935_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6678755","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li B, Liu N, Wang P, He J. Evaluation of different anthropometric indicators for screening for nonalcoholic fatty liver disease in elderly individuals. Int J Endocrinol. 2021;2021:6678755.","journal-title":"Int J Endocrinol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03935-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:00:59Z","timestamp":1770314459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03935-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3935"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03935-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before enrollment, a specialized nurse took written informed consents from all patients. The ethics committee of Tehran University of Medical Sciences approved the study protocol. The study complied with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}